Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now
Read now
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Read now
Timothy E Albertson, Susan Murin, Mark E Sutter & James A Chenoweth. (2017) The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials. Pragmatic and Observational Research 8, pages 175-181.
Read now
Read now
Matthew William McCarthy, Vidmantas Petraitis & Thomas J. Walsh. (2017) Combination therapy for the treatment of pulmonary mold infections. Expert Review of Respiratory Medicine 11:6, pages 481-489.
Read now
Read now
Articles from other publishers (5)
Jayne E. Hastedt, Per Bäckman, Antonio Cabal, Andy Clark, Carsten Ehrhardt, Ben Forbes, Anthony J. Hickey, Guenther Hochhaus, Wenlei Jiang, Stavros Kassinos, Philip J. Kuehl, David PrimeYoen-Ju Son, Simon TeagueUlrika Tehler & Jennifer Wylie. (2023) iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products. Molecular Pharmaceutics 21:1, pages 164-172.
Crossref
Crossref
Adrian HobsonAdrian Hobson. 2023. The Medicinal Chemistry of Glucocorticoid Receptor Modulators. The Medicinal Chemistry of Glucocorticoid Receptor Modulators
25
36
.
Franziska Roth‐Walter, Ian M. Adcock, Cristina Benito‐Villalvilla, Rodolfo Bianchini, Leif Bjermer, Gaetano Caramori, Luigi Cari, Kian Fan Chung, Zuzana Diamant, Ibon Eguiluz‐Gracia, Edward F. Knol, Antonios G. A. Kolios, Francesca Levi‐Schaffer, Giuseppe Nocentini, Oscar Palomares, Pier Giorgio Puzzovio, Frank A. Redegeld, Betty C. A. M. van Esch & Cristiana Stellato. (2019)
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An
EAACI
Taskforce on Immunopharmacology position paper
. Allergy 74:3, pages 432-448.
Crossref
Crossref
George Bardsley, Peter Daley-Yates, Amanda Baines, Rodger Kempsford, Mathew Williams, Tony Mallon, Irene Braithwaite, Kylie Riddell, Shashidhar Joshi, Philippe Bareille, Richard Beasley & James Fingleton. (2018) Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial. Respiratory Research 19:1.
Crossref
Crossref
Philippe Devillier, Marc Humbert, Alain Boye, Wolfgang Zachgo, Loretta Jacques, Carol Nunn, Sarah West, Andy Nicholls, Zeina Antoun, Luminita Spinu & Jean-Marie Grouin. (2018) Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial. Respiratory Medicine 141, pages 111-120.
Crossref
Crossref